BAY 1165747 (BAY-747) is a new, structurally distinct, soluble guanylate cyclase (sGC) stimulator with potential in the treatment of resistant hypertension . Identified through ultrahigh-throughput screening, it features an imidazo[1,2-a]pyridine core, distinct from the [...]
5 minute read
May 29, 2023
BAY-747: Potential for An Improved sGC Stimulator for Resistant Hypertension
BAY-747
oral QD sGC stimulator Ph. I in healthy volunteers completed from HTS + optimization J. Med. Chem., April 11, 2023 Bayer, Wuppertal, DE
Loading...
